Eli Lilly's lower-priced insulin goes on sale amid drug price debate

The saddest part of this is that it took this long when: 1) the patent expired in 2013: and 2) since Lily is the brand name manufacturer, essentially what they will do is make the same product, and put a generic label on Monday’s batch and the brand name label on Tuesday’s batch.

And YET, it’s still not as cheap as the exact same product, from the exact same facility, is sold in Canada and Mexico.